Interchange Capital Partners’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-6,084
Closed -$241K 314
2024
Q4
$241K Sell
6,084
-192
-3% -$7.27K 0.09% 215
2024
Q3
$214K Buy
+6,276
New +$177K 0.08% 246
2021
Q1
Sell
-306
Closed -$14K 1057
2020
Q4
$14K Buy
+306
New +$14.2K 0.01% 724

Other funds holding VCYT

Interchange Capital Partners's VCYT Position: Q1 2025 in Review

Interchange Capital Partners sold out of Veracyte (VCYT) in Q1 2025, closing a stake of 6,084 shares — an estimated $241K sold.

Interchange Capital Partners first reported a position in VCYT in Q4 2020 and held it in 3 quarters. The position peaked at $241K in Q4 2024. 287 funds tracked by Wall St. Rank hold VCYT as of Q1 2025.

  • Interchange Capital Partners reported no remaining Veracyte position as of Q1 2025 after selling out during the quarter.
  • Interchange Capital Partners sold 6,084 Veracyte shares in Q1 2025, an estimated $241K.
  • Interchange Capital Partners first reported a position in Veracyte in Q4 2020 and held it in 3 quarters.
  • Interchange Capital Partners's Veracyte position peaked at $241K in Q4 2024.
  • 287 funds tracked by Wall St. Rank held Veracyte as of Q1 2025.

Based on Interchange Capital Partners's 13F filing for Q1 2025, filed 30 Apr 2025.